It is also at the center of 2026's regulatory shift in April the FDA removed it from the list that restricted compounding, and it is one of seven peptides under formal advisory review on July 2324, 2026
Ipamorelin produced no increase in either hormone at any dose tested, including doses 200-fold above its GH ED50
They are often designed to improve the bioavailability of active drugs by increasing their amount in target cells and reducing off-target effects
It is important to appreciate, however, that the increased risk relates to a disorder that is relatively uncommon. NAION is rare, affecting up to 10 out of 100,000 people in the general population
Enhances overall recovery after intense workouts, physical trauma, or major surgery